Albanese Government Announces $100 Million Arthritis Research Mission
The Albanese Government has announced a landmark $100 million investment over the next decade to establish a new Arthritis and Musculoskeletal Conditions Research Mission, aimed at improving the prevention, diagnosis, and treatment of arthritis and related conditions.
The initiative will be funded through the Medical Research Future Fund (MRFF) and will bring together researchers, healthcare professionals, industry partners, and patients to drive innovation and improve outcomes for Australians living with these debilitating diseases.
More than seven million Australians are affected by arthritis and other musculoskeletal conditions. These lifelong conditions can develop at any age and often have a significant impact on a person’s ability to work, remain active, and maintain their quality of life.
The new mission forms part of the Albanese Government’s broader commitment to strengthening Australia’s health and medical research sector. Funding will come from the 2026–27 Federal Budget commitment of $508.5 million over four years, which will increase annual MRFF investments from $650 million to $1 billion by 2030–31.
Prime Minister Anthony Albanese said the investment would make a meaningful difference to millions of Australians affected by arthritis.
“For millions of Australians, living with arthritis isn’t just an ache or pain; it affects their ability to work, stay active, and enjoy everyday life,” Mr Albanese said.
He described the $100 million commitment as a “gamechanger” that would support Australian researchers in developing better treatments, improving diagnosis, and delivering long-awaited medical breakthroughs.
Health Minister Mark Butler said the government’s health and medical research investments are focused on improving the lives of Australians and supporting world-class scientific innovation.
“We have world-class researchers in Australia whose ideas could transform health outcomes for future generations,” Mr Butler said.
Arthritis Australia Chief Executive Officer Louise Hardy welcomed the announcement, describing it as a historic moment for the arthritis community.
“This is a truly historic day for our community. The announcement gives hope to millions of Australians of all ages living with the pain of arthritis,” Ms Hardy said.
She added that the mission would help drive urgently needed research breakthroughs, including earlier diagnosis, improved treatments, and the potential development of cures.
The government says the mission will help position Australia at the forefront of arthritis and musculoskeletal research while delivering long-term benefits for patients and the healthcare system.
Source: Australian Government Media Release
